Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.

Documenti analoghi

• Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
  di: Mohanty, N. K., et al.
  Pubblicazione: (2008)
• Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
  di: Ord, J J, et al.
  Pubblicazione: (2005)
• Intravesical therapy for urothelial carcinoma of the bladder
  di: Manoharan, M.
  Pubblicazione: (2011)
• Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder
  di: Elzein, Fatehi, et al.
  Pubblicazione: (2016)
• Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma
  di: Paroni, Rita, et al.
  Pubblicazione: (2001)